Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000516 |
---|---|
Receipt number | R000000624 |
Scientific Title | Japanese Research of Cholesterol and Diabetes Mellitus |
Date of disclosure of the study information | 2006/11/10 |
Last modified on | 2017/11/15 09:44:19 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2006/11/07 15:55:23 | ||
2 | Update | 2007/12/02 10:03:38 | Publication of results |
|
3 | Update | 2009/11/07 16:04:11 | Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
4 | Update | 2009/11/07 16:05:32 | Last name of lead principal investigator Last name of lead principal investigator |
|
5 | Update | 2009/11/07 16:11:13 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Results Results |
|
6 | Update | 2010/05/07 10:44:49 | Date analysis concluded |
|
7 | Update | 2010/12/05 11:28:47 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
8 | Update | 2010/12/05 11:30:19 | Other related information |
|
9 | Update | 2011/06/18 20:17:53 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
10 | Update | 2012/05/16 16:59:01 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
11 | Update | 2012/05/16 17:00:45 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
12 | Update | 2015/06/17 15:30:51 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
13 | Update | 2015/06/17 15:31:35 | Email |
|
14 | Update | 2015/11/07 14:15:51 | Date trial data considered complete Date analysis concluded |
|
15 | Update | 2017/06/28 11:22:07 | Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Division name Division name Address Address TEL Name of primary person or sponsor Institute Institute Organization Category of Funding Organization |
|
16 | Update | 2017/11/15 09:44:19 | Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |